Everyone has been talking about personalized medicine for years. Where does the wave of digitization and the associated collection and analysis of data have the greatest benefit for patients? What are the best practice examples in P4 medicine (preventive, personalized, precise and participative) and in D4 medicine (drugs, diagnostics, devices and data)? And, which companies have a chance to survive in the market with their ideas, because they have already found the right investors for their innovation and/or their offer is honored/reimbursed?
The latest developments in this field will be examined from various perspectives at the personalized medicine theme day. Experts from biotech, pharmaceutical, IT, digital health and diagnostics companies, associations and clusters will discuss the current status and future direction of Personalized Medicine.